Literature DB >> 18853270

A novel transgenic mice model for venous malformation.

Yan An Wang1, Jia Wei Zheng, Zhao Liang Fei, Xin Quan Jiang, Zhu Gang Wang, Jian Fei, Zhi Yuan Zhang.   

Abstract

Vascular anomalies are most commonly seen in the head and neck region, and there is no animal model available of this disease until now. The purpose of this study was to construct a conditional murine polyomavirus middle T antigen gene (PyMT) transgenic mice model, in order to provide a basis for the treatment of vascular anomalies in vivo, as well as the study of PyMT's molecular function. A new conditional transgenic vector based on Tet-On system was constructed successfully. After the experiment in vitro, pronuclear microinjection method was used to introduce the purified transgene into the chromosomes of fertilized mice eggs, and five transgenic positive mice were obtained. The transgenic positive animals went down to future generation by hybridization. After induction of PyMT's expression in the F1 generation, three transgenic mice developed venous malformation which was confirmed histopathologically. The mice model generated could be used as a tool to study venous malformation, as well as the function of PyMT gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853270     DOI: 10.1007/s11248-008-9224-1

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  19 in total

Review 1.  The insulation of genes from external enhancers and silencing chromatin.

Authors:  Bonnie Burgess-Beusse; Catherine Farrell; Miklos Gaszner; Michael Litt; Vesco Mutskov; Felix Recillas-Targa; Melanie Simpson; Adam West; Gary Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-01       Impact factor: 11.205

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Epigenetic silencing of a foreign gene in nuclear transformants of Chlamydomonas.

Authors:  H Cerutti; A M Johnson; N W Gillham; J E Boynton
Journal:  Plant Cell       Date:  1997-06       Impact factor: 11.277

4.  Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene.

Authors:  R L Williams; S A Courtneidge; E F Wagner
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

5.  The Tet-On system in transgenic mice: inhibition of the mouse pdx-1 gene activity by antisense RNA expression in pancreatic beta-cells.

Authors:  H Lottmann; J Vanselow; B Hessabi; R Walther
Journal:  J Mol Med (Berl)       Date:  2001-06       Impact factor: 4.599

6.  Association of the 5'HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits.

Authors:  F Taboit-Dameron; B Malassagne; C Viglietta; C Puissant; M Leroux-Coyau; C Chéreau; J Attal; B Weill; L M Houdebine
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

7.  Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis.

Authors:  Lynn Vitale-Cross; Panomwat Amornphimoltham; Galen Fisher; Alfredo A Molinolo; J Silvio Gutkind
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

8.  Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.

Authors:  Z Zhu; B Ma; R J Homer; T Zheng; J A Elias
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

9.  Tetracycline-inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vector.

Authors:  Cristina M Bäckman; YaJun Zhang; Barry J Hoffer; Andreas C Tomac
Journal:  J Neurosci Methods       Date:  2004-10-30       Impact factor: 2.390

10.  Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors.

Authors:  Maider Zabala; Lin Wang; Ruben Hernandez-Alcoceba; Wolfgang Hillen; Cheng Qian; Jesus Prieto; M Gabriela Kramer
Journal:  Cancer Res       Date:  2004-04-15       Impact factor: 12.701

View more
  1 in total

1.  Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.

Authors:  Sandra D Castillo; Elena Tzouanacou; May Zaw-Thin; Inma M Berenjeno; Victoria E R Parker; Iñigo Chivite; Maria Milà-Guasch; Wayne Pearce; Isabelle Solomon; Ana Angulo-Urarte; Ana M Figueiredo; Robert E Dewhurst; Rachel G Knox; Graeme R Clark; Cheryl L Scudamore; Adam Badar; Tammy L Kalber; Julie Foster; Daniel J Stuckey; Anna L David; Wayne A Phillips; Mark F Lythgoe; Valerie Wilson; Robert K Semple; Neil J Sebire; Veronica A Kinsler; Mariona Graupera; Bart Vanhaesebroeck
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.